Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Non-Current Debt (2019 - 2026)

Clene (CLNN) posted Non-Current Debt of $5.4 million for Q2 2026, up 43.65% on a QoQ basis from $3.7 million in Q4 2025, and up 16.35% year-over-year from $4.6 million in Q2 2025.

Analysis

Clene (CLNN) Non-Current Debt (2019 - 2026) Analysis & Trends

Clene has reported Non-Current Debt for 8 years, with the latest figure at $5.4 million in Q2 2026.

  • On a quarterly basis, Non-Current Debt rose 16.35% year-over-year to $5.4 million in Q2 2026; TTM through Jun 2026 was $5.4 million, a 16.35% increase from a year earlier, with the FY2025 full-year figure at $3.7 million, down 18.85% from the prior year.
  • Non-Current Debt was $5.4 million for Q2 2026 at Clene, up from $3.7 million in the prior quarter.
  • The five-year high for Non-Current Debt was $16.0 million in Q2 2023, with the low at $1.7 million in Q3 2024.
  • Average Non-Current Debt over 5 years is $6.9 million, with a median of $4.6 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2024: Non-Current Debt soared 697.83% in 2022, then tumbled 89.11% in 2024.
  • Over 5 years, Non-Current Debt stood at $9.5 million in 2022, then sank by 80.03% to $1.9 million in 2023, then soared by 143.4% to $4.6 million in 2024, then slipped by 18.85% to $3.7 million in 2025, then surged by 43.65% to $5.4 million in 2026.
  • The last three Non-Current Debt figures came in at $5.4 million (Q2 2026), $3.7 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 37.34 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 62.48 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Clene 45.69 Mn 45.69 Mn 54,000.00 5.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.37 Mn
Dec 31, 2025 3.74 Mn
Sep 30, 2025 4.57 Mn
Jun 30, 2025 4.62 Mn
Mar 31, 2025 1.94 Mn
Dec 31, 2024 4.61 Mn
Sep 30, 2024 1.67 Mn
Jun 30, 2024 1.75 Mn
Mar 31, 2024 1.82 Mn
Dec 31, 2023 1.89 Mn
Sep 30, 2023 6.68 Mn
Jun 30, 2023 16.02 Mn
Mar 31, 2023 6.71 Mn
Dec 31, 2022 9.48 Mn
Sep 30, 2022 15.73 Mn
Jun 30, 2022 15.55 Mn
Mar 31, 2022 14.71 Mn
Dec 31, 2021 14.48 Mn
Sep 30, 2021 14.61 Mn
Jun 30, 2021 10.38 Mn